Concourse Financial Group Securities, Inc. A Ikido Pharma Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	N/A
Q1 2024 Apr 30, 2024	BUY	N/A
Q4 2023 Feb 07, 2024	BUY	N/A
Q3 2023 Oct 30, 2023	BUY	N/A
Q3 2023 Oct 25, 2023	BUY	N/A
Q2 2023 Aug 10, 2023	BUY	N/A
Q1 2023 May 15, 2023	BUY	$3.46 - $4.07 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$3.07 - $7.21 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$5.6 - $7.03 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$4.59 - $7.99 $0 - $0

Others Institutions Holding AIKI

# of Institutions

Shares Held

461K

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

193K
Shares

$734,889
0.0% of portfolio
Black Rock Inc. New York, NY

72.5K
Shares

$275,572
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

46.1K
Shares

$175,221
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

45.9K
Shares

$174,518
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

39.8K
Shares

$151,365
0.0% of portfolio

View Full List

About AIkido Pharma Inc.

Ticker AIKI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,485,100
Market Cap $20.8M
Description
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...

More about AIKI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account